Management of carriers of pathogenic germline variants in "moderate risk" ovarian cancer susceptibility genes
Click on the links to download the UKCGG guidelines for the management of carriers of pathogenic germline variants in RAD51C and RAD51D.
You may also be interested in reading about the national consensus meeting we held in October 2021 to determine best practice in testing of these and other "moderate risk" ovarian cancer susceptibility genes, and management of carriers in whom variants in such genes are identified. For information about this and other UKCGG consensus meetings click here.
A copy of the manuscript arising from the meeting is available at the link here above.